NEWS PAGE
October 2009:
Dr. Timothy Nurkiewciz Earns NIH Challange Grant through the AARA
|
Timothy R. Nurkiewicz, Ph.D. has been awarded one of the highly competitive Challange Grants, provided by the National Institutes of Health (NIH). As part of the American and Recovery Reinvestment Act (AARA), the NIH created the Challenge Grants in Health and Science Research to fund high-impact projects across the country in biomedical and behavioral research or public health.
Dr. Nurkiewicz's project entitled, "Mircovascular Health and Nanoparticle Exposure", was chosen for award. This program is highly competitive, receiving applications from some 20,000 scientists and research teams across the country. A number of fewer than 800 were selected for funding. Dr. Nurkiewicz will receive a funding amount of $1,000,000.
Click here to read more information about Dr. Nurkiewicz's Grant. 
|
August 2009:
Dr. S. Jamal Mustafa Co-Authors Book
 |
|
 |
Dr. S. Jamal Mustafa |
|
Learn more about this book by clicking on the image above. |
S. Jamal Mustafa, Ph.D., Assistant Vice President for Research and Professor of Physiology and Basic Pharmaceutical Sciences, has recently co-authored a book titled, “Adenosine Receptors in Health and Disease.” The book, co-authored with Constance N. Wilson will be available on October 4, 2009.
This book is written for libraries, researchers and clinicians in the fields of pharmacology, physiology and cell biology as well as persons in pharmaceutical and biopharma industries. Sprnger is the publishing company and is one of the world's leading scientific, techniology and medicine publishers.
The soon to be released book is part of the “Handbook of Experimental Pharmacology Series”, which is one of the most authoritative and influential book series in pharmacology. “It provides critical and comprehensive discussions of the most significant areas of pharmacological research, written by leading international authorities. Each volume in the series represents the most informative and contemporary account of its subject available, making it an unrivalled reference source.” |
|
August 2009:
Loretta Cain Awarded T32 Training Grant
Loretta Cain has been selected as one of six students chosen for appointment to the NIH Cardiovascular and Pulmonary Disease Training Grant. They join two other students currently being supported by the grant. The grant, also known as a T32 training grant, supports broad and fundamental research to help ensure that a diverse and highly trained workforce is available in the future to assume leadership roles as independent scientists in academic institutions.
Starting on July 1, 2009; appointments are made for 12 month intervals for a maximum of 24 months. Many factors went into the selection process, such as:
- Undergraduate grades
- GRE scores
- Grades so far in the first two years of the program
- Student progress towards thesis proposal
- Future goals
Specific requirements for continued participation, the student must:
- Participate in specific courses, WIP seminars, cardiopulmonary journal club and any other courses designed specifically for this training grant
- Applying for a pre-doctoral fellowship to AHA, ALA and other funding agencies
- Comply with all NIH guidelines and policies
- Meet WVU requirements needed to complete a PhD degree
This pre-doctoral interdisciplinary training grant provides stipends, tuition and health insurance expenses for Ph.D. students conducting heart, lung and vascular disease research. Students are paired with grant-funded faculty mentors to conduct research relevant to coronary artery disease, asthma, hypertension, cardiac failure, inflammation, and obesity-related lung and vascular disorders. These are topics that are directly related to the health problems associated with West Virginia’s population. Our goal is to train the next generation of research scholars who will have expertise and interests aligned with such disease issues.”
Dr. S. Jamal Mustafa serves as the Principal Investigator of this project, and Dr. Richard Dey serves as the Co-Director.
Other students supported on this training grant for 2009 - 2010 are:
- Walter Baseler
- Lindsey Carrell
- Adam Goodwill
- Megan James
- Kimberly Miede
- Mariam Sharif-Sanyani
- Katrina Sites
- Ernest Young
For more information on the Research Training Program in the Cardiovascular and Pulmonary Sciences, click here. |
August 2009:
Dr. Timothy R. Nurkiewicz Appointed to Two Editorial Boards
-Editorial Board for the Journal of Inhalation Toxicology-
Dr. Timothy Nurkiewicz has been appointed to the Editorial Board for the Journal of Inhalation Toxicology. Dr. Nurkiewicz appointment began on June 1 and will last for two-years. As a member of the Editorial Board, Dr. Nurkiewicz will be reviewing colleagues’ manuscripts and making constructive suggestions to improve the circulation and quality of the journal. Dr. Nurkiewicz can make a valuable contribution by utilizing his knowledge, experience and international reputation as a cardiovascular toxicologist.
This year the Journal begins its twenty-first year of publication. A few of the factors that contribute to the Journal’s continued growth and success are the publication of 14 issues each year and that is becoming the key forum for international exchange of the latest in pulmonary toxicology. The last impact factor for the journal was 1.886. Of the top 20 journals, associated with air pollution, The Journal of Inhalation Toxicology was ranked at #8. Last year there were 99 manuscripts accepted. About one-half of the accepted manuscripts were submitted from researchers outside of the United States.
The categories of papers accepted last year were about: |
Animal Tox
|
38% |
Epi/Human/Clinical Tox
|
27% |
Modeling/Dosimetry
|
13% |
In Vitro
|
5% |
Technology and Reviews
|
17% |
The Journal also publishes several supplemental issues such as The 10th International Inhalation Symposium Held in Hannover, Germany and The Symposium on Air Quality and Alternative Transportation Fuels.
- Editorial Board for the Journal of Toxicology and Enviromental Health -
Dr. Nurkiewicz has also been appointed to another Editorial Board. This time his manuscript reviews and application of experience will be in support of the Journal of Toxicology and Environmental Health.
Published twenty-four times per year, this authoritative journal features strictly refereed original research in the field of environmental toxicology in general. It also features research in special interest fields, such as: target organ toxicities, immunotoxicology, risk assessment, carcinogenesis, mutagenesis, ecotoxicology, environmental factors affecting health, and aquatic toxicology. Strong emphasis is placed on the toxicological effects of natural and anthropogenic environmental pollutants and their action on both intact organisms and in vitro systems. “Increased attention is being placed on the results of epidemiological studies of select groups of workers in exposed populations.”
The readership of the Journal consists of toxicologists, environmentalists, pharmacologists, health care professionals, biochemists, radiation biologists, epidemiologists, safety and health administrators, physicians, oncologists, and hazardous substances operators.
You can learn more about these journals by clicking on the following images:
July 2009:
Dr. Robert Brock to Serve on JPET Editorial Board
Robert Brock, Ph.D., FAHA has been elected to serve, effective immediately, on the Editorial Board of the Journal of Pharmacology and Experimental Therapeutics (JPET).
The JPET is a publication of The American Society for Pharmacology and Experimental Therapeutics (ASPET).
ASPET is a 4,800 member scientific society whose members conduct basic and clinical pharmacological research in academia, industry and the government.
Their members research efforts help develop new medicines and therapeutic agents to fight existing and emerging diseases.
This year marks 100 years of publication for JPET and it is playing an increasing role in helping with the communication of ASPET member efforts. The journal was created by the founder of the Society, Dr. John Jacob Abel, and launched 6 months after the Society was started. The Special Libraries Association named JPET one of the “100 most influential journals of biology and medicine over the 100 years of the association’s existence” earlier this year. It is a leading
research journal in the field of pharmacology published since 1909, JPET provides broad coverage of all aspects of the interactions of chemicals with biological systems,
including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as analgesics,
drug abuse, metabolism and disposition, chemotherapy, and toxicology.
JPET currently has approximately 1,800 subscribers. The online version of the journal receives an average of almost 450,000 hits per month. JPET is an open access journal—all articles are published in manuscript form immediately upon acceptance and are freely available. Fully formatted and copyedited versions are made freely available 12 months after publication.
To learn more about the JPET, click image: 
To learn more about ASPET, click image: 
July 2009:
|
|
Dr. Matthew Boegehold Receives AHA Grant-In-Aid Award
Congratulations to Dr. Matthew Boegehold once again! Dr. Boegehold has recently been awarded another Grant-In-Aid from the American Heart Association (AHA), entitled “Effect of Juvenile Growth on Endothelium-Dependent Control of Microvascular Tone.”
This award comes from the Great Rivers Affiliate (GRA) of the AHA. The GRA awarded 11 grants out of 144 applications, resulting in a 7.64% success rate for this series. The GRA includes the following states: Delaware, Kentucky, Ohio, Pennsylvania, and West Virginia. |
| |
|
|
July 2009:
Dr. Timothy R. Nurkiewicz Selected as President of Cardiovascular Toxicology Specialty Section for Society of Toxicology
Timothy R. Nurkiewicz, Ph.D. has been selected as the president of a new Specialty Section for the Society of Toxicology (SOT). SOT is a leading global force and rouse for advancing toxicology. SOT fosters cutting-edge research through its 18 Regional Chapters, 6 Special Interest Groups and now 22 Specialty Sections. 
SOT’s Specialty Sections provide forums for networking and exchanging information with members interested in particular focus areas of toxicology. The annual receptions and meetings of the Specialty Sections at the SOT Annual Meeting are ideal opportunities to network with colleagues.
SOT’s Strategic Priorities include: Increase Scientific Impact, Advocate for the Value of Toxicology, Build for the Future of Toxicology, Expand and Deepen Member Engagement, and Strengthen Organizational Effectiveness. The SOT includes more than 6,000 members from nearly 50 different countries. Members are drawn from academic institutions, industry, government service among others. They are active in a host of related fields and professions. All members partner with SOT in advance science to enhance human, animaland environmental health.
Dr. Nurkiewicz will preside over the new Specialty Section entitled, “CardiovascularToxicology Specialty Section” (CVTSS). The objectives of the Cardiovascular Toxicology Specialty Section of the Society of Toxicology shall be:
- Unite cardiovascular toxicologists from academia, government, industry, and the private sector.
- Promote scientific endeavors that identify, prevent and/or ameliorate cardiovascular toxicities.
- Develop scientific programs, position statements and outreach activities.
- Facilitate graduate education/training and the recruitment of new cardiovascular scientists.
Dr. Nurkiewicz explained that, “The Cardiovascular Toxicology Specialty Section (CVT SS) of the Society of Toxicology (SOT) is being established to lead the response to these challenges in our immediate and not so distant futures. The CVT SS is committed to excellence in all aspects of research and will serve to unite cardiovascular toxicologists from academia, government, industry and the private sector. This unification will serve to merge conventional techniques and methods in an interdisciplinary fashion that will fortify the education of our students and fellows that will become the next generation of cardiovascular toxicologists.
Given the inherent complexity of human biological systems, and the history of cardiovascular toxicology; it is obvious that the combined talents of diverse scientists and clinicians alike are required to achieve significant advances in this field. The CVT SS recognizes this requirement, and will be designed to foster scientific interactions at all levels, contribute to position statements and develop unique scientific sessions for National, Regional and Specialty Meetings of the SOT.”
Charter Meeting of the Cardiovascular Specialty Section
Dr. Nurkiewicz plans to hold the CVT SS Charter Meeting during the annual Society of Toxicology Meeting in Salt Lake City next March, 2010. All SOT members (full, associate, post-doc and student members alike) are invited to attend our first public reception. Dr. Nurkiewicz stated, “the CVT SS is dedicated to advancing cardiovascular toxicology and serving the scientists that populate this field. This broad-reaching commitment will serve not only to unite scientists from academia, government, industry, and the private sector but also to actively promote issues germane to cardiovascular toxicology and facilitate the training of the next generation of scholars in this field. In this first meeting of the CVSS, the groundwork necessary to initiate these commitments will be laid.” |
July 2009:
 |
WVU surgeon volunteers to treat injured soldiers from Iraq, Afghanistan
Dr. Alexandre C. d'Audiffret, a surgeon at West Virginia University, has volunteered to fill a slot in the surgery rotation of Landstuhl Regional Medical Center at Ramstein Air Force Base in Germany where many of the soldiers injured in Iraq and Afghanistan are treated.
Dr.d'Audiffret began his stint July 4 and will return July 19. He joins 51 other members of the Society for Vascular Surgery in relieving the limited number of vascular surgeons in the military who are filling positions in military hospitals in the United States and internationally. Details: http://www.health.wvu.edu/newsreleases/news-details.aspx?ID=1228 |
| |
|
July 2009:
Dr. Michael R. Morissette receives AHA Beginning Grant-In-Aid Award
Congratulations to Dr. Michael R. Morissette, who recently was awarded a Beginning Grant-In-Aid from the Great Rivers Affiliate (GRA) of the American Heart Association. Dr. Morissette will receive the two-year award at $66,000 per year.
A Beginning Grant-In-Aid promotes the independent status of promising beginning scientists. 15 awards were funded out of 123 applications which reflected a 12.2% success rate for applications to the GRA Spring 2009 Beginning Grant-in-Aid program.
The Great Rivers Affiliate of the AHA consists of Delaware, Kentucky, Ohio, Pennsylvania and West Virginia.
|
July 2009:
Dr. Robert Brock Appointed Graduate Director of Celluar and Integrative Physiology Program
Congratulations to Robert Brock, Ph.D., F.A.H.A on his appointment as Graduate Director of the Cellular and Integrative Physiology Program starting July 1, 2009.
Dr. Brock’s roll will position him to support the goal of the Cellular and Integrative Physiology Graduate Program to engage students in creating and enhancing innovative approaches to the life sciences. Students will leave the program better able to identify important unsolved scientific questions, and with an appreciation of how to select problems for which quantitative and theoretical approaches can be applied.
This multidimensional program includes activities in integrative and systems physiology, pathophysiology, pharmacology, translational research, small animal physiology, biomedical engineering and biophysics. It also integrates information from genetics, functional genomics and proteomics into whole animal and human physiology. This interactive and cross-disciplinary environment, together with an atmosphere filled with enthusiasm and passion for scientific discovery, makes the Program a uniquely exciting place for doing research and training students.
The Cellular and Integrative Physiology Graduate Program employs a multidisciplinary approach to modern life sciences, drawing on faculty expertise from several departments and centers in the WVU School
of Medicine.
In serving
his new role, Dr. Brock will work with research
faculty, consisting of
scientists from:
- Center for Cardiovascular & Respiratory Sciences
- NIOSH
-
Center for Neuroscience
- Blanchette Rockefeller Neurosciences Institute
Specific topics of research emphasis include:
- Hemodynamics and Cardiovascular Control in Health and Disease
- Microcirculation and Cellular Biophysics
- Respiratory Function and Control in Health and Disease
- Neuroendocrine Control of Reproduction
- Neural Control of Sensory Physiology
|
June 2009:
New Appointees Selected for NIH Cardiovascular and Pulmonary Disease Training Grant
NHLBI-T32 Pre-Doctoral Training Grant
The following students were chosen for appointment to the NIH Cardiovascular and Pulmonary Disease Training Grant (NHLBI-T32 Pre-Doctoral training grant) starting July 1, 2009:
New Appointees |
| |
|
 |
 |
|
|
Adam Goodwill
Cellular and Integrative Physiology |
Megan James
Cellular and Integrative Physiology |
Walter Baseler
Exercise Physiology |
Ernest Young
Immunology & Microbial Pathogenesis |
Katrina Porter
Cellular and Integrative Physiology |
_______________________________________________________________________________________________________________________________________________
The following students are the current trainees of the NIH Cardiovascular and Pulmonary Disease Training Grant (NHLBI-T32 Pre-Doctoral training grant):
Current Trainees |
| |
| |
 |
 |
 |
|
| |
Lynnsey Carrell
Neuroscience |
Kim Miede
Physiology & Pharmacology |
Mariam Sharif-Sanyani
Pharmaceutical & Pharmacological Sciences |
|
Not pictured is Alison Kohan, from Dr. Lisa Salati's lab, she will be receiving the grant until July 1, 2009, when she will be leaving for Cincinnati.
For details about the NIH Cardiovascular and Pulmonary Disease Training Grant (NHLBI-T32 Pre-Doctoral training grant),
click here.
May 2009:
Dr. Tim Nurkiewicz's Research on Ultra Fine Particulate featured by West Virginia Public Broadcasting |
|
Timothy Nurkiewicz, Ph.D., Assistant Professor of Physiology and Pharmacology informs others about the effects of diesel exhaust and it's dangers on the health of West Virginians.
Dr. Nurkiewicz's research on ultra fine particulate is featured in a recent information campaign by West Virginia Public Broadcasting, entitled "Air Pollution in West Virginia: What You Can't See Could Hurt You." The title reflects exactly why Dr. Nurkiewicz's research is so vital to the people of West Virginia.
You can hear the interview with Dr. Nurkiewicz, and other WVU researchers on your local WV Public Broadcasting Radio Station. Click here to see list of Local Radio Stations. You can also download the MP3 version by clicking on this link. You can view the story via video by clicking on this link.
|
May 2009:
Adam Goodwill and Himani Vejandla win Julie Betschart Research Award
Dr. Chris Baylis gives Featured Seminar
Adam Goodwill and Himani Vejandla (see photos below), have been selected as the 2009 Julie Betschart Research Award winners by the Physiology Department of West Virginia University.
The Julie Betschart Symposium is an oral competition for students in the Cellular and Integrative Physiology program. To participate, a student must have presented an abstract within the past year. The presentation consists of a 10-12 minute talk, followed by three to five minutes of a question and answer session. A small panel of faculty serves as judges to determine the winners. The first place winner's name is inscribed on a plaque which is then placed in the Van Liere Conference Room.
This year’s event was comprised of student presentations, posters, and a featured seminar which took place in the John E. Jones Conference Room May 22. As a special feature, Dr. Chris Baylis gave the featured seminar, titled “Nitric Oxide Deficiency in Chronic Kidney Disease”. “We were very pleased to have Chris back here this year to give the invited lecture” Dr. Hileman said.
|
Julie Betschart
This endeared award is named after Julie Betschart. Julie was with the Physiology department when she was diagnosed with brain cancer.
A Dr. Chris Baylis established the Julie Betschart Research Symposium with the aid of Julie's mother, Jean Roemer, as a tribute to Julie.
Dr. Stan Hileman, Associate Professor of Physiology, assumed leadership of the award after Chris left for the University of Florida in 2004. Dr. Hileman continues on with the commitment to honor Julie and carry on the tribute Dr. Baylis implemented.
|
|
| Adam Goodwill
Adam Goodwill received first place honors with his presentation, “Increased Vascular Thrombaxane Generation Restrains Arteriolar Dilation to Hypaxia in Obese Zucker Rats.” Adam is a member of Dr. Jefferson Frisbee’s lab. Dr. Frisbee is an Associate Professor of Physiology and Pharmacology.
|
Himani Vejandla
Second place honors were presented to Himani Vejandla for her presentation, “Protection Against Mitochondrial Dysfunction: One More Feather in the Cap of C-Peptide”. Himani is a member of Dr. Robert Brock’s lab. Dr. Brock is the Graduate Chair of Cellular and Integrative Physiology Program, Associate Professor of Physiology and Pharmacology and a Wyeth Research Scholar.
|
May 2009:
Dr. Hollander given Dean's Award for Excellence in Research
Dr. Hollander receives Dean's Award from Dr. James Brick.
John M. Hollander, Ph.D., Assistant Professor, Division of Exercise Physiology, recently received the Dean’s Award for Excellence in Research. The award recognizes an individual or group that has demonstrated excellence over time in a specific area; that excellence must be recognized by others beyond the immediate worksite; and must involve continued contributions in the area of excellence for years to come. Dr. Hollander is a prime example of an individual that fits the criteria for this award.
The award was presented during the Excellence Awards/Distinguished Teacher Ceremony On Monday, April 20 in the Okey Patteson Auditorium. A private reception in the Second Floor Conference Room of the new Erma Byrd Biomedical Research Center followed the ceremony.
Dr. Hollander completed a 4 year postdoctoral fellowship at the University of California-San Diego in Cardiovascular Biology and assumed the position of Assistant Project Scientist at the same institution before joining our West Virginia University School in 2005.
Dr. Hollander received the prestigious Director's New Innovator Award from the National Institutes of Health to study "The Mechanisms of Diabetic Cardiomyopathy in Mitochondria Subpopulations.” This Award was created to support a small number of new investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems. He is principal investigator on this five year grant and will study the impact of type 1 diabetic insult on spatially distinct mitochondrial subpopulations using advanced proteomic and genomic methodologies, in an effort to facilitate advancements in therapeutic development.
Dr. Hollander is a consultant on another NIH grant to study the Physiological consequences of hypoxia and lung disease. He additionally has a Grant-in -Aid from the American Heart Association to study the differential response of mitochondria populations to ischemia/reperfusion injury, and determine the efficacy of mPHGPx overexpression.
Dr. Hollander is also serving on an NIH working group on “interdisciplinary approaches to Diabetic Heart Disease: Mechanisms, biomarkers and Therapeutic Target.” The objective of this working group is to address the genetic, molecular and environmental basis underlying the cardiovascular complications of diabetes and to find new diagnostic tools, identify risk stratification and development of novel therapeutic targets for diabetic heart disease. The intent is to identify new research opportunities in the area and come up with recommendations for future studies.
He is also the mentor on an American Heart Association predoctoral fellowship from the American Heart Association. Dr. Hollander continues to show exemplary service to the WVU School of Medicine through his hard work and dedication.
April 2009:
Jefferson C. Frisbee, Ph.D. named Editor-In-Chief Elect for Microcirculation Journal
Jefferson C. Frisbee, Ph.D., has been selected by the Microcirculatory Society, Inc.’s Executive Council and the Publications Committee to serve as the new Editor-In-Chief (EIC) for their official journal, “Microcirculation”. The journal, Microcirculation”, features original contributions that are the  result of investigations contributing significant new information relating to the microcirculation addressed at the intact animal/human, organ, cellular, or molecular level. The journal also publishes state-of-the-art reviews that address frontier areas or new advances in technology in the fields of microcirculatory disease and function.
Using 2009 as a transition year, Dr. Frisbee will be acquiring the duties from Dr. William Jackson at Michigan State University (the outgoing EIC) and transferring EIC operations to WVU in time for January 1, 2010. Under Dr. Frisbee’s guidance, several members of the CCRS will be very active as members of the Microcirculatory Society, Inc. (MCS). This will benefit WVU with opportunities for increased collaborations in the field.
The mission of the Microcirculatory Society, Inc. is to actively encourage and promote all forms of innovative research and teaching, leading to an increase in understanding of microcirculatory function in health and disease.
The Microcirculatory Society was organized in 1954 with Edward Bloch as the first president. It was organized from isolated and independent groups or individuals concerned with research on microcirculation. The Society first met in conjunction with the 67th annual meeting of the American Association of Anatomists.
As EIC, Dr. Frisbee will serve as the chairman of the Editorial Board and will nominate the Associate Editors and the Editorial Board. The Editorial Board members will be appointed for a two-year term.
In general, the EIC is responsible for the technical content, quality, and timeliness of the journalissues. The EIC has responsibility for all final decisions pertaining to the content and quality of each issue of the Journal. The EIC is responsible for determining overall policies of the Journal, establishingeditorial guidelines, appointing editorial boards and selecting reviewers, chairing and directing the editorial board, soliciting manuscript submissions, and coordinating and overseeing the peer-review process to ensure and maintain the timely and high-quality publication of the Journal. The EIC is also responsible for the correspondence with authors, editors, reviewers, and readers.
You can review the journal by clicking on the Microcirculation image below and for more information on MCS see http://microcirc.org/.
April 2009:
|
S. Jamal Mustafa, Ph.D. Earns $2.5 Million Grant Renewal for Heart Research
The National Heart, Lung and Blood Institute has renewed its support of the research of West Virginia University scientist S. Jamal Mustafa, Ph.D., whose studies have helped improve understanding of the chemicals that regulate blood flow to the heart.
Click image below to read complete story
from the WVU Health News.
|
Mohammed Nayeem, Ph.D., Co-Investigator on grant (left), and S. Jamal Mustafa, Ph.D. (right)
|
|
28-29, April 2009:
CCRS Researchers Receive High Honors at Van Liere Events
The Van Liere Events take place annually and allows student researchers in health sciences to work side by side with top-flight faculty mentors. It is an opportunity for the researchers to present their work via poster presentations and oral presentations. These presentations take months to prepare and reflect on the hard work and quality of research by our students.
The interest in this event is growing as evidenced by the 128 abstracts submitted this year. Tom Saba stated, “This superb participation reflects the continued growth and interest in basic, clinical and population-based translational research as well as graduate education at WVU Health Sciences and our four component Schools of Medicine, Dentistry, Nursing and Pharmacy”.
The Van Liere Awards are named for an early WVU medical dean and physiology researcher Dr. E. J. Van Liere who was also the first Dean of the SOM. The winners were those researchers that best meet the criteria such as research design and interpretation, significance of resesearch, as well as organization and clarity.
This year CCRS proudly congratulates Amanda LeBlanc, Ph.D. for taking 1st Place on Poster Presentation in the Post Doc Fellows Category and Erinne Dabkowski, Ph.D. on taking 3rd Place in Oral Presentations and 2nd Place on Poster Presentations in the Basic Sciences 3 Category.
On Tuesday, April 28, 2009, the researchers participated in the E.J. Van Liere Research Convocation by giving oral presentations on their projects. The presentations took place in the Hostler Auditorium at the Health Sciences Center.
On Wednesday, April 29, 2009, students joined with fellows and faculty in sharing their research with classmates and colleagues. The presentation of posters took place at the WVU Erickson Alumni Center.
Cick to see CCRS Researchers and their posters Van Liere Photos
Click to see CCRS Researchers' Abstracts....
|
